
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
AMPKβ2 CRISPR/Cas9 KO Plasmid (h) | sc-403537 | 20 µg | $397.00 |
PRKAB2 encodes the β2 regulatory subunit of AMP-activated protein kinase (AMPK), a heterotrimeric serine/threonine kinase that senses cellular energy status through AMP/ADP-to-ATP ratios. AMPKβ2 contributes to complex assembly and localization and links upstream activation to phosphorylation cascades that restrain anabolic programs while promoting catabolic pathways, including glucose uptake, fatty acid oxidation, and autophagy via cross-talk with mTOR and related nutrient-sensing networks. Through these functions, AMPKβ2 is relevant to studies of metabolic stress adaptation, mitochondrial homeostasis, and cell growth control. Altered AMPK signaling has been associated with metabolic disorders and cancer biology, making PRKAB2 a useful node for probing energy-dependent regulation of proliferation and survival pathways.
AMPKβ2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PRKAB2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PRKAB2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PRKAB2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish AMPKβ2 protein expression.
This CRISPR knockout system enables efficient generation of PRKAB2-deficient cell models for investigation of AMPKβ2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.